KLK3 and prostate cancer: Individual parameters were evaluated using univariate analysis for possible correlation with any progression of prostate cancer, R2D:4D, L2D:4D, initial PSA, PSA at 6 month after treatment, bone metastasis, lymph node metastasis influenced the progression (Table 3).